Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Reprod Toxicol. 2016 Jun 16;65:11–17. doi: 10.1016/j.reprotox.2016.06.011

Table 2. Distribution of serum PFAS concentrations (ng/mL) by pregnancy status (n=389).

PFAA (ng/mL) LOD %
<LOD
(n=332)		 Pregnant(n=332) %
<LOD
(n=57)		 Infertile (n=57)
Md IQR Md IQR
Et-PFOSA-AcOH 0.2 97 0 0, 0 96 0 0, 0.1
Me-PFOSA-AcOH 0.2 26 0.3 0.1, 0.5 26 0.3 0.1, 0.4
PFDeA 0.2 9 0.4 0.2, 0.6 5 0.3 0.2, 0.5
PFNA 0.1 2 1.2 0.7, 1.7 0 1.1 0.8, 1.4
PFOSA* 0.1 92 0 0, 0 81 0 0, 0
PFOS 0.2 0 12.2 8.3, 17.8 0 12.1 7.1, 17.1
PFOA 0.1 0.3 3.3 2.2, 4.9 0 3.2 2.5, 4.3

NOTE: Infertile women represent women who did not become pregnant after 12 months of trying.

*

p<0.05

IQR, interquartile range; LOD, limits of detection; Md, median

2-N-ethyl-perfluorooctane sulfonamide acetate (Et-PFOSA-AcOH),

2-N-methyl-perfluorooctane sulfonamido acetate (Me-PFOSA-AcOH)

perfluorodecanoate (PFDeA)

perfluorononanoate (PFNA)

perfluorooctane sulfonamide (PFOSA)

perfluorooctane sulfonate (PFOS)

perfluorooctanoate (PFOA)